SCHEDULE 13G/A: Founder Dr. Sudhir Srivastava Discloses Over 63% Beneficial Ownership in SS Innovations International

Dr. Sudhir Srivastava and affiliated entities have filed an amended Schedule 13G, revealing a significant beneficial ownership stake of 63.1% in SS Innovations International, Inc.'s common stock as of December 31, 2024.

Summary

• Dr. Sudhir Srivastava, the founder, beneficially owns 107,818,790 shares of SS Innovations International, Inc. common stock, representing 63.1% of the outstanding shares.
• This ownership includes 103,197,140 shares held by Sushruta PVT LTD, 32,000 shares directly held by Dr. Srivastava, and options to purchase 4,364,931 shares.
• Additionally, Dr. Srivastava's beneficial ownership includes 224,719 shares convertible from a 7% Convertible One-Year Promissory Note held by Sushruta PVT LTD.
• Sushruta PVT LTD, a Bahamian entity in which Dr. Srivastava holds a 100% interest, beneficially owns 103,421,589 shares, equating to 60.5% of the common stock.
• Sudhir Srivastava Innovations PTE LTD, a Singaporean entity also 100% owned by Dr. Srivastava, does not beneficially own any shares as reported in this filing.
• The percentage ownership calculations are based on 170,873,415 shares of common stock outstanding as of January 14, 2025, as reported in the issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously filed beneficial ownership statement.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the founder's very high beneficial ownership, which typically signals strong commitment and alignment of interests. However, it's a factual disclosure, not a performance report, so the positive sentiment is limited to the implications of ownership structure.

Positives

• Dr. Sudhir Srivastava, the founder, maintains a substantial beneficial ownership of 63.1%, indicating strong alignment with shareholder interests and a significant vested stake in the company's future.
• The high insider ownership by the founder and related entities suggests confidence in the company's long-term prospects and strategic direction.

Negatives

• The concentration of ownership by a single individual and affiliated entities could potentially limit the liquidity of the stock and influence corporate governance decisions significantly.

Risks

• Concentrated ownership by Dr. Sudhir Srivastava and his affiliated entities (Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD) means that a single individual has substantial control over the company's direction, which could pose risks related to decision-making and potential conflicts of interest for minority shareholders.
• The reliance on a 7% Convertible One-Year Promissory Note held by Sushruta PVT LTD, convertible into 224,719 shares, introduces a debt instrument that can convert into equity, potentially diluting existing shareholders if not managed effectively.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Management Comments

• Dr. Sudhir Srivastava, M.D., is reported as having a 100% interest in Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD, indicating his direct control over these entities' holdings.

Industry Context

This filing is a standard regulatory disclosure of significant beneficial ownership, common across all publicly traded companies. It does not provide specific industry trends or competitive analysis but highlights the concentrated ownership structure within SS Innovations International, Inc., which is typical for founder-led companies, particularly in early or growth stages.

Related Party Transactions

• Dr. Sudhir Srivastava has a 100% interest in Sushruta PVT LTD and Sudhir Srivastava Innovations PTE LTD, which are reporting persons and hold significant shares, indicating related party control over these entities' holdings.

Stakeholder Impact

• Shareholders: The high concentration of ownership by Dr. Sudhir Srivastava and his affiliated entities means that his decisions will heavily influence the company's direction, potentially impacting minority shareholder rights and stock liquidity.
• Management: Dr. Srivastava's significant stake reinforces his control and influence over strategic and operational decisions.

Key Dates

Keywords

SS Innovations International, Sudhir Srivastava, Beneficial Ownership, Schedule 13G, Common Stock, Insider Ownership, Sushruta PVT LTD, Corporate Governance, SEC Filing, Equity Stake